HealthEquity Property, Plant, and Equipment 2014-2025 | HQY
HealthEquity property, plant, and equipment from 2014 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- HealthEquity property, plant, and equipment for the quarter ending April 30, 2025 was $0.003B, a 37.58% decline year-over-year.
- HealthEquity property, plant, and equipment for 2025 was $0.003B, a 46.13% decline from 2024.
- HealthEquity property, plant, and equipment for 2024 was $0.006B, a 53.25% decline from 2023.
- HealthEquity property, plant, and equipment for 2023 was $0.013B, a 44.97% decline from 2022.
| HealthEquity Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025 | $3 |
| 2024 | $6 |
| 2023 | $13 |
| 2022 | $23 |
| 2021 | $29 |
| 2020 | $33 |
| 2019 | $8 |
| 2018 | $8 |
| 2017 | $5 |
| 2016 | $4 |
| 2015 | $3 |
| 2014 | $2 |
| 2013 | $1 |
| HealthEquity Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025-04-30 | $3 |
| 2025-01-31 | $3 |
| 2024-10-31 | $4 |
| 2024-07-31 | $5 |
| 2024-04-30 | $5 |
| 2024-01-31 | $6 |
| 2023-10-31 | $8 |
| 2023-07-31 | $9 |
| 2023-04-30 | $11 |
| 2023-01-31 | $13 |
| 2022-10-31 | $16 |
| 2022-07-31 | $18 |
| 2022-04-30 | $21 |
| 2022-01-31 | $23 |
| 2021-10-31 | $25 |
| 2021-07-31 | $27 |
| 2021-04-30 | $27 |
| 2021-01-31 | $29 |
| 2020-10-31 | $32 |
| 2020-07-31 | $35 |
| 2020-04-30 | $36 |
| 2020-01-31 | $33 |
| 2019-10-31 | $35 |
| 2019-07-31 | $10 |
| 2019-04-30 | $8 |
| 2019-01-31 | $8 |
| 2018-10-31 | $9 |
| 2018-07-31 | $9 |
| 2018-04-30 | $9 |
| 2018-01-31 | $8 |
| 2017-10-31 | $7 |
| 2017-07-31 | $6 |
| 2017-04-30 | $6 |
| 2017-01-31 | $5 |
| 2016-10-31 | $5 |
| 2016-07-31 | $4 |
| 2016-04-30 | $3 |
| 2016-01-31 | $4 |
| 2015-10-31 | $4 |
| 2015-07-31 | $3 |
| 2015-04-30 | $3 |
| 2015-01-31 | $3 |
| 2014-10-31 | $3 |
| 2014-07-31 | $3 |
| 2014-04-30 | |
| 2014-01-31 | |
| 2013-10-31 | |
| 2013-07-31 | |
| 2013-01-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.991B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.850B | 26.98 |
| Elevance Health (ELV) | United States | $84.468B | 10.90 |
| CVS Health (CVS) | United States | $83.959B | 10.44 |
| Cencora (COR) | United States | $56.658B | 19.71 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.415B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.653B | 17.56 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.432B | 0.00 |
| Solventum (SOLV) | United States | $12.967B | 13.73 |
| CochLear (CHEOY) | Australia | $12.826B | 0.00 |
| ICON (ICLR) | Ireland | $11.783B | 10.95 |
| Revvity (RVTY) | United States | $11.516B | 19.82 |
| Viatris (VTRS) | United States | $10.434B | 3.58 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| Medpace Holdings (MEDP) | United States | $8.943B | 23.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.378B | 14.46 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.305B | 25.35 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 36.47 |
| Sotera Health (SHC) | United States | $3.162B | 17.97 |
| Surgery Partners (SGRY) | United States | $2.782B | 36.18 |
| Alignment Healthcare (ALHC) | United States | $2.710B | 0.00 |
| Concentras Parent (CON) | United States | $2.631B | 15.21 |
| Organon (OGN) | United States | $2.600B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.537B | 97.72 |
| PACS (PACS) | United States | $1.951B | 0.00 |
| Ardent Health (ARDT) | United States | $1.877B | 8.00 |
| Premier (PINC) | United States | $1.799B | 13.66 |
| Progyny (PGNY) | United States | $1.792B | 39.45 |
| GoodRx Holdings (GDRX) | United States | $1.754B | 35.07 |
| Teladoc Health (TDOC) | United States | $1.328B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| Establishment Labs Holdings (ESTA) | $1.084B | 0.00 | |
| CareDx (CDNA) | United States | $1.064B | 16.62 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.670B | 10.14 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.476B | 39.17 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.301B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.258B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| Oncology Institute (TOI) | United States | $0.192B | 0.00 |
| So-Young (SY) | China | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.113B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.095B | 0.00 |
| KindlyMD (NAKA) | United States | $0.085B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |